Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist experienced improvements in their quality of life.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/biologic-plus-glp-1-agonist-improves-quality-life-psoriatic-2026a10002s0?src=rss

Author :

Publish date : 2026-01-28 21:28:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

Nearly Half of Americans Expected to Have Obesity in the Next 10 Years

Related Posts

Nearly Half of Americans Expected to Have Obesity in the Next 10 Years

A Call to Consider Patients’ Medication List When Prescribing Cancer Immunotherapy

How to Survive Night Shifts as a Resident

Next DSM Insights; FDA Reviewing Non-Stimulant ADHD Drug; 10M People Microdosing

Viral and Nonviral NICU Infection Rates Diverged During the COVID Pandemic

NIH Data Misused for ‘Race Science’; RFK Jr.’s Autism Committee; NIH Panels at Risk

Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

Nearly Half of Americans Expected to Have Obesity in the Next 10 Years

A Call to Consider Patients’ Medication List When Prescribing Cancer Immunotherapy

How to Survive Night Shifts as a Resident

Next DSM Insights; FDA Reviewing Non-Stimulant ADHD Drug; 10M People Microdosing

Viral and Nonviral NICU Infection Rates Diverged During the COVID Pandemic

NIH Data Misused for ‘Race Science’; RFK Jr.’s Autism Committee; NIH Panels at Risk

Study Suggests Some Tap Water May Raise Blood Pressure

Categories

Archives